Related Experiment Video
Updated: Jun 12, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Precision medicine's blind spot: Rebalancing the evidence base to reflect women's health
Chloe E Bird1,2, Hamad Al Ibrahim3,4
1Center for Research on Women's Health, Sex Differences, and Population Health, Tufts Medical Center, Boston, MA, USA.
Abstract:
Precision medicine requires an evidence base that reflects women's biology, demanding reforms in funding, study design, and sex-disaggregated reporting.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bias in Epidemiological Studies
Pharmacogenomics: Identification of New Drug Targets
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blinding
